Larvol Delta - 89bio-Presents-New-Analyses-Evaluating-Pegozafermin-and-Potential-Benet-of-NonInvasive-Tests-from-the-ENLIVEN-Phase-2b-Trial-in-MASH-Patients-at-AASLD-The-Liver-Meeting-2024

pegozafermin (BIO89-100) - 89Bio

https://www.globenewswire.com/news-release/2024/11/15/2981977/0/en/89bio-Presents-New-Analyses-Evaluating-Pegozafermin-and-Potential-Benefit-of-Non-Invasive-Tests-from-the-ENLIVEN-Phase-2b-Trial-in-MASH-Patients-at-AASLD-The-Liver-Meeting-2024.html

Nov 15, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next